Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Three-dimensional Measurements of Diabetic Foot Ulcers

11 mars 2019 mis à jour par: Line Bisgaard Jørgensen, Odense University Hospital

Three-dimensional Measurements for Monitoring Wound Healing of Diabetic Foot Ulcers

Diabetic foot ulcers constitute an increasing health problem in Denmark concurrent with an ageing population and an increase in diabetes prevalence. Diabetic foot ulcers belong to the most serious and costly complications. Several studies have found that the size and depth of the ulcer is one of the major etiologic factors for delayed healing. Wound measurement is important in the monitoring of the wound healing process. For the last decade different 3D (three-dimensional) techniques for measuring wounds have been proposed in order to measure wound volume, but none of the technologies have been widely used. A 3D Wound Assessment Monitor (WAM) camera has been developed, which is able to measure wound size in 3D and to assess wound characteristics.

The investigators hypothesize that three-dimensional measurements of diabetic foot ulcers are feasible in the assessment of wound healing. A prospective cohort study is conducted in which newly admitted patients with a diabetic foot ulcer are included at the first visit at the multidisciplinary clinic. The patients are followed for one year or until complete wound healing, amputation or death. The four wound measurements: 2D area, 3D area, perimeter and volume are measured using the 3D-WAM camera with frequent intervals. Patient anthropometrics and wound data are collected during the study and correlated to the wound healing.

Aperçu de l'étude

Description détaillée

Method

Newly admitted patients with a diabetic foot ulcer are included at the first visit in the multidisciplinary clinic. The data mentioned below are collected at the first visit and the following examinations are performed including 3D photos. The wound size (2D area, 3D area, perimeter and volume) are estimated from the photos using the 3D-WAM camera. The wound examination is repeated after 2, 4, 8, 12, 24, 36 and 52 weeks or until healing of the wound. The wound healing is estimated using changes in wound size per time unit. Patients are treated by standard ulcer treatment methods and are unaffected by the project per se. During the trial the different methods of treatment are noted including changes from initial treatment. The variables will be quantified after one year depending on time to heal, establishment of a chronic ulcer (non-healing after one year) or an amputation has been performed.

At baseline the following patient data will be collected:

  • Demographic data: gender, age
  • Smoking habits
  • Time period between onset of wound to first visit in the multidisciplinary clinic
  • Body Mass Index
  • Comorbidity using Charlson Comorbidity Index score
  • Type of diabetes, duration of diabetes
  • Diabetic complications including retinopathy, albuminuria, coronary heart diseases and neuropathy

The following examinations will be performed at baseline:

  • Blood pressure measurement
  • Peripheral blood pressure
  • Examination for neuropathy using monofilament
  • Blood samples from patients with a diabetic foot ulcer

The clinical examination of the ulcer are performed at baseline and after 2, 4, 8, 12, 24, 36 and 52 weeks or until wound healing:

  • Size of wound (2D area, 3D area, perimeter, volume) measured using the 3D-WAM camera
  • Size of wound in 2D area using the digital imaging method with the software ImageJ
  • Location of the ulcer
  • Classification of ulcer: granulation, necrosis, epithelialisation
  • Secretory potential
  • Foot deformity
  • Bone affection - if osteitis is suspected an x-ray is taken
  • Signs of infection

The different types of ulcer treatment is registered for every ulcer:

  • Type of bandage
  • Antibiotics (local, systemic)
  • Revision (method, frequency),
  • Surgery

Effect variables

  • Wound 2D area, 3D area, perimeter and volume
  • Variation in 2D and 3D area measurements during the study period
  • Percentage change in wound size after 2, 4, 8, 12, 24, 36 and 52 weeks

Endpoints

  • Wound healing
  • Amputations
  • Chronic wound (non-healing after 1 year)
  • Death

Significance

This project seeks to clarify whether 3D photos of wounds will provide accurate structural measures to illuminate the background for delayed ulcer healing, and thereby to create platform for a more evidence based treatment algorithm.

Type d'étude

Observationnel

Inscription (Réel)

150

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Odense, Danemark, 5000
        • University Centre of Wound Healing, Odense University Hospital (OUH)

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

Newly admitted patients with diabetic foot ulcer to University Centre for Wound Healing, Odense University Hospital.

La description

Inclusion Criteria:

  • Newly admitted patients with diabetic foot ulcers
  • 18 years or older

Exclusion Criteria:

  • Superficial wound (less than 5x5 mm with no substantial loss of subcutaneous tissue)
  • Non-compliance (dementia, mental disorders)

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Diabetic foot ulcers
Newly referred patients with diabetic foot ulcers from the multidisciplinary clinic: University Centre for Wound healing, Odense University Hospital, Denmark.
Three-dimensional wound measurement (2D area, 3D area, perimeter, volume) using 3D-WAM camera
Autres noms:
  • 3D-WAM camera

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Wound healing change quantified using the 3D-WAM camera
Délai: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
The 3D wound measurements at week 2, 4, 8, 12, 24, 36 and 52 are compared to the baseline measurement at week 0.
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
Wound healing change quantified using digital imaging method
Délai: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
The 2D wound measurements at week 2, 4, 8, 12, 24, 36 and 52 are compared to the baseline measurement at week 0.
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
The variability in 2D area and 3D area measurements
Délai: Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
The variability in 2D area (digital imaging method) and 3D area wound measurements (3D-WAM camera) at week 0, 2, 4, 8, 12, 24, 36 and 52 are compared
Photos are taken at week 0, 2, 4, 8, 12, 24, 36 and 52 weeks
Diabetes type is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
Type 1 and 2
Baseline until healing, amputation or chronic wound (52 weeks)
Diabetes duration is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
In years
Baseline until healing, amputation or chronic wound (52 weeks)
BMI (kg/m2) is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
kg/m2
Baseline until healing, amputation or chronic wound (52 weeks)
Charlson index score is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
In groups
Baseline until healing, amputation or chronic wound (52 weeks)
HbA1c is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
mmol/mol
Baseline until healing, amputation or chronic wound (52 weeks)
Ischemia is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
Ischemia is defined by ankle pressure below 70 mmHg and/or toe pressure below 45 mmHg
Baseline until healing, amputation or chronic wound (52 weeks)
Neuropathy is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
Neuropathy is measured by Semmes Weinstein monofilament examination
Baseline until healing, amputation or chronic wound (52 weeks)
Wound duration is compared to outcome of the wound
Délai: Baseline until healing, amputation or chronic wound (52 weeks)
In weeks
Baseline until healing, amputation or chronic wound (52 weeks)

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Quality of life (Questionaires) using 36-Item Short Form Survey (SF-36) is compared to outcome of the wound
Délai: Baseline, 24 and 52 weeks
The higher the score the less disability
Baseline, 24 and 52 weeks

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Knud Yderstræde, MD, PhD, Department of Endocrinology, Odense University Hospital

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 août 2015

Achèvement primaire (Réel)

1 décembre 2018

Achèvement de l'étude (Réel)

1 décembre 2018

Dates d'inscription aux études

Première soumission

15 avril 2015

Première soumission répondant aux critères de contrôle qualité

19 avril 2015

Première publication (Estimation)

22 avril 2015

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

13 mars 2019

Dernière mise à jour soumise répondant aux critères de contrôle qualité

11 mars 2019

Dernière vérification

1 mars 2019

Plus d'information

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

Essais cliniques sur Diabète sucré, Type 2

S'abonner